Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application

Author： Corash L.  

Publisher： Elsevier

ISSN： 1473-0502

Source： Transfusion and Apheresis Science, Vol.25, Iss.3, 2001-12, pp. : 179-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inactivation of infectious pathogens in labile blood components: meeting the challenge

By Corash L.  

Transfusion Clinique et Biologique, Vol. 8, Iss. 3, 2001-06 ,pp. : 138-145

Elsevier

Access to resources Recommend Favorite

Use of riboflavin for photoinactivation of pathogens in blood components

By Schuyler R.  

Transfusion and Apheresis Science, Vol. 25, Iss. 3, 2001-12 ,pp. : 189-190

Elsevier

Access to resources Recommend Favorite

Potential Clinical Benefits and Cost Savings of Universal Leucocyte-Depletion of Blood Components

By Murphy M.F.  

Transfusion and Apheresis Science, Vol. 19, Iss. 4, 1998-12 ,pp. : 343-346

Elsevier

Access to resources Recommend Favorite

Potential Clinical Benefits and Cost Savings of Universal Leucocyte-Depletion of Blood Components

By Murphy M.F.  

Transfusion Science, Vol. 19, Iss. 4, 1998-12 ,pp. : 343-346

Elsevier

Access to resources Recommend Favorite

Increased anticoagulant osmolality improves separation of leukocytes from red blood cells (RBC)

By Knutson F.   Loof H.   Hogman C.F.  

Transfusion and Apheresis Science, Vol. 21, Iss. 3, 1999-12 ,pp. : 185-191

Elsevier

Access to resources Recommend Favorite